INMD NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

InMode Ltd · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 15.14 USD
-0.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 6.3% above the Trend Line and sits at 60.2% of its 52-week range. The latest completed week returned -0.2%, after a 2.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is bullish with 47/100 conviction, while the latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 48 out of 100
Latest Close 15.14 USD 31 Jul 2026
1W Return -0.2% latest completed week
4W Return 2.3% short-term follow-through
12W Return 8.5% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.2% Latest completed week; four-week move 2.3%. Indicator stack 12/87 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 47/100 conviction; expected move 5.9%. News sentiment 48/100 70 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 6.3% above the Trend Line and sits at 60.2% of its 52-week range. The latest completed week returned -0.2%, after a 2.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3912-week average 0.18

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.39Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.3% over four weeks, 8.5% over 12 weeks, and 10.2% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W-0.2%
4W2.3%
12W8.5%
26W-3.6%
52W10.2%
Active trend streak2 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.36Latest activity-pressure read.
Pressure change162.9%Four-week change in activity pressure.
Leadership-4.25Latest relative-leadership reading.
RS change60.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength90/100Blend of value, momentum, and quality. Underlying universe rank 11; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum28/100Medium-term price momentum. Underlying universe rank 73; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework96/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
10.0x
Price divided by trailing earnings.
Price / sales
2.3x
Market value relative to trailing revenue.
EV / EBITDA
4.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
19.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
77.8%
Gross profit retained from each unit of revenue.
Operating margin
27.3%
Operating profit retained from revenue.
Free-cash-flow margin
24.8%
Free cash flow generated from revenue.
Return on invested capital
32.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.5%
Latest one-year revenue growth.
EPS growth
-50.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-24.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
6.6%
Net share repurchases relative to market value.
Shareholder yield
6.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

INMD shows bullish options pressure with a 47/100 conviction score, put-call volume ratio of 0.01, expected move of 5.9%, and Sharemaestro trend signal active.

Conviction47/100
Expected move5.9%
Put/call volume0.01
Pressure100
Speculation3
Volatility43
Trend agreement2
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 70 relevant articles.

9 positive · 51 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move5.9%Nearest-chain priced movement where available.
52-week drawdown-9.6%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+9.2%Week of 26 Jun.
Worst week-9.7%Week of 27 Feb.
Latest week-0.2%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains7
Flat weeks0
Modest losses13
Sharp losses3
Recent vol3.0%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 2/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.39; No reversal markers Factors75/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 9; Small Cap Core rank 12 SVQF96/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 33.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options46/100

INMD shows bullish options pressure with a 47/100 conviction score, put-call volume ratio of 0.01, expected move of 5.9%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 5.9% Sentiment48/100

Weighted news tone is neutral across 70 relevant articles.

InMode Ltd. (NASDAQ: INMD) director receives 2,000 RSU equity award Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202615.14 USD-0.2%14.24 USD17.96 USD1.36-4.253.3MOn
24 Jul 202615.17 USD-1.9%14.23 USD18.13 USD1.36-3.762.2MOn
17 Jul 202615.47 USD1.2%14.21 USD18.31 USD1.47-3.743.5MOff
10 Jul 202615.28 USD3.2%14.18 USD18.50 USD0.94-9.073.8MOff
3 Jul 202614.80 USD1.2%14.15 USD18.69 USD0.52-10.752.6MOff
26 Jun 202614.63 USD9.2%14.14 USD18.84 USD0.21-11.507.2MOff
19 Jun 202613.40 USD-0.4%14.12 USD18.98 USD-0.22-22.922.5MOff
12 Jun 202613.45 USD-0.7%14.15 USD19.13 USD-0.05-21.032.4MOff
5 Jun 202613.54 USD-2.8%14.17 USD19.28 USD-0.04-19.113.0MOff
29 May 202613.93 USD1.4%14.20 USD19.41 USD-0.09-21.023.9MOff
22 May 202613.74 USD-1.2%14.23 USD19.54 USD0.01-20.456.6MOff
15 May 202613.90 USD-0.4%14.28 USD19.66 USD-0.04-19.125.3MOff
8 May 202613.96 USD-3.1%14.33 USD19.78 USD0.01-19.585.8MOff
1 May 202614.41 USD0.1%14.37 USD19.91 USD-0.11-13.121.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.